271 related articles for article (PubMed ID: 25145330)
1. Development and characterization of siRNA lipoplexes: Effect of different lipids, in vitro evaluation in cancerous cell lines and in vivo toxicity study.
Khatri N; Baradia D; Vhora I; Rathi M; Misra A
AAPS PharmSciTech; 2014 Dec; 15(6):1630-43. PubMed ID: 25145330
[TBL] [Abstract][Full Text] [Related]
2. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
[TBL] [Abstract][Full Text] [Related]
3. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H
J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333
[TBL] [Abstract][Full Text] [Related]
4. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes.
Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B
Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245
[TBL] [Abstract][Full Text] [Related]
5. Quantitative silencing of EGFP reporter gene by self-assembled siRNA lipoplexes of LinOS and cholesterol.
Metwally AA; Blagbrough IS; Mantell JM
Mol Pharm; 2012 Nov; 9(11):3384-95. PubMed ID: 23057412
[TBL] [Abstract][Full Text] [Related]
6. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
[TBL] [Abstract][Full Text] [Related]
7. Effect of cationic lipid in cationic liposomes on siRNA delivery into the lung by intravenous injection of cationic lipoplex.
Hattori Y; Nakamura M; Takeuchi N; Tamaki K; Shimizu S; Yoshiike Y; Taguchi M; Ohno H; Ozaki KI; Onishi H
J Drug Target; 2019 Feb; 27(2):217-227. PubMed ID: 30024300
[TBL] [Abstract][Full Text] [Related]
8. Effect of the combination of cationic lipid and phospholipid on gene-knockdown using siRNA lipoplexes in breast tumor cells and mouse lungs.
Hattori Y; Tang M; Aoki A; Ezaki M; Sakai H; Ozaki KI
Mol Med Rep; 2023 Oct; 28(4):. PubMed ID: 37594053
[TBL] [Abstract][Full Text] [Related]
9. Efficient and safe delivery of siRNA using anionic lipids: Formulation optimization studies.
Kapoor M; Burgess DJ
Int J Pharm; 2012 Aug; 432(1-2):80-90. PubMed ID: 22575754
[TBL] [Abstract][Full Text] [Related]
10. Exploring the potential of novel pH sensitive lipoplexes for tumor targeted gene delivery with reduced toxicity.
Kumar Y; Kuche K; Swami R; Katiyar SS; Chaudhari D; Katare PB; Banerjee SK; Jain S
Int J Pharm; 2020 Jan; 573():118889. PubMed ID: 31765778
[TBL] [Abstract][Full Text] [Related]
11. cRGD grafted siRNA nano-constructs for chemosensitization of gemcitabine hydrochloride in lung cancer treatment.
Khatri N; Rathi M; Baradia D; Misra A
Pharm Res; 2015 Mar; 32(3):806-18. PubMed ID: 24792823
[TBL] [Abstract][Full Text] [Related]
12. cRGD grafted liposomes containing inorganic nano-precipitate complexed siRNA for intracellular delivery in cancer cells.
Khatri N; Baradia D; Vhora I; Rathi M; Misra A
J Control Release; 2014 May; 182():45-57. PubMed ID: 24631861
[TBL] [Abstract][Full Text] [Related]
13. PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity.
Belletti D; Tosi G; Forni F; Lagreca I; Barozzi P; Pederzoli F; Vandelli MA; Riva G; Luppi M; Ruozi B
Eur J Pharm Biopharm; 2016 Feb; 99():7-17. PubMed ID: 26625717
[TBL] [Abstract][Full Text] [Related]
14. Hydration of lipoplexes commonly used in gene delivery: follow-up by laurdan fluorescence changes and quantification by differential scanning calorimetry.
Hirsch-Lerner D; Barenholz Y
Biochim Biophys Acta; 1999 Nov; 1461(1):47-57. PubMed ID: 10556487
[TBL] [Abstract][Full Text] [Related]
15. Effects of cationic lipids in cationic liposomes and disaccharides in the freeze-drying of siRNA lipoplexes on gene silencing in cells by reverse transfection.
Hattori Y; Hu S; Onishi H
J Liposome Res; 2020 Sep; 30(3):235-245. PubMed ID: 31185779
[TBL] [Abstract][Full Text] [Related]
16. Convenient targeting of stealth siRNA-lipoplexes to cells with chelator lipid-anchored molecules.
Herringson TP; Altin JG
J Control Release; 2009 Nov; 139(3):229-38. PubMed ID: 19595724
[TBL] [Abstract][Full Text] [Related]
17. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
Kim HK; Davaa E; Myung CS; Park JS
Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
[TBL] [Abstract][Full Text] [Related]
18. Optimal combination of cationic lipid and phospholipid in cationic liposomes for gene knockdown in breast cancer cells and mouse lung using siRNA lipoplexes.
Hattori Y; Tang M; Torii S; Tomita K; Sagawa A; Inoue N; Yamagishi R; Ozaki KI
Mol Med Rep; 2022 Aug; 26(2):. PubMed ID: 35686555
[TBL] [Abstract][Full Text] [Related]
19. Efficient in vitro gene therapy with PEG siRNA lipid nanocapsules for passive targeting strategy in melanoma.
Resnier P; LeQuinio P; Lautram N; André E; Gaillard C; Bastiat G; Benoit JP; Passirani C
Biotechnol J; 2014 Nov; 9(11):1389-401. PubMed ID: 25262914
[TBL] [Abstract][Full Text] [Related]
20. Physicochemical characterization of anionic lipid-based ternary siRNA complexes.
Kapoor M; Burgess DJ
Biochim Biophys Acta; 2012 Jul; 1818(7):1603-12. PubMed ID: 22465067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
